🎉 M&A multiples are live!
Check it out!

uniQure Valuation Multiples

Discover revenue and EBITDA valuation multiples for uniQure and similar public comparables like Pharming, Galapagos, and Vivoryon Therapeutics.

uniQure Overview

About uniQure

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.


Founded

2012

HQ

United States of America
Employees

480

Website

uniqure.com

Financials

LTM Revenue $30.7M

LTM EBITDA -$169M

EV

$194M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

uniQure Financials

uniQure has a last 12-month revenue of $30.7M and a last 12-month EBITDA of -$169M.

In the most recent fiscal year, uniQure achieved revenue of $27.1M and an EBITDA of -$161M.

uniQure expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See uniQure valuation multiples based on analyst estimates

uniQure P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $15.8M $27.1M XXX XXX XXX
Gross Profit $103M $2.2M XXX XXX XXX
Gross Margin 651% 8% XXX XXX XXX
EBITDA -$253M -$161M XXX XXX XXX
EBITDA Margin -1598% -593% XXX XXX XXX
Net Profit -$127M -$308M XXX XXX XXX
Net Margin -800% -1137% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

uniQure Stock Performance

As of April 15, 2025, uniQure's stock price is $9.

uniQure has current market cap of $496M, and EV of $194M.

See uniQure trading valuation data

uniQure Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$194M $496M XXX XXX XXX XXX $-4.63

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

uniQure Valuation Multiples

As of April 15, 2025, uniQure has market cap of $496M and EV of $194M.

uniQure's trades at 6.3x LTM EV/Revenue multiple, and -1.2x LTM EBITDA.

Analysts estimate uniQure's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for uniQure and 10K+ public comps

uniQure Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $194M XXX XXX XXX
EV/Revenue 7.2x XXX XXX XXX
EV/EBITDA -1.2x XXX XXX XXX
P/E -2.1x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -1.0x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get uniQure Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

uniQure Valuation Multiples

uniQure's NTM/LTM revenue growth is 88%

uniQure's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.4M for the same period.

Over next 12 months, uniQure's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate uniQure's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for uniQure and other 10K+ public comps

uniQure Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 71% XXX XXX XXX XXX
EBITDA Margin -593% XXX XXX XXX XXX
EBITDA Growth -36% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -505% XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $0.4M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 187% XXX XXX XXX XXX
R&D Expenses to Revenue 530% XXX XXX XXX XXX
Opex to Revenue 700% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

uniQure Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics and Regenerative Medicine comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

uniQure M&A and Investment Activity

uniQure acquired  XXX companies to date.

Last acquisition by uniQure was  XXXXXXXX, XXXXX XXXXX XXXXXX . uniQure acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by uniQure

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About uniQure

When was uniQure founded? uniQure was founded in 2012.
Where is uniQure headquartered? uniQure is headquartered in United States of America.
How many employees does uniQure have? As of today, uniQure has 480 employees.
Who is the CEO of uniQure? uniQure's CEO is Mr. Matthew C. Kapusta.
Is uniQure publicy listed? Yes, uniQure is a public company listed on NAS.
What is the stock symbol of uniQure? uniQure trades under QURE ticker.
When did uniQure go public? uniQure went public in 2014.
Who are competitors of uniQure? Similar companies to uniQure include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of uniQure? uniQure's current market cap is $496M
What is the current revenue of uniQure? uniQure's last 12-month revenue is $30.7M.
What is the current EBITDA of uniQure? uniQure's last 12-month EBITDA is -$169M.
What is the current EV/Revenue multiple of uniQure? Current revenue multiple of uniQure is 6.3x.
What is the current EV/EBITDA multiple of uniQure? Current EBITDA multiple of uniQure is -1.2x.
What is the current revenue growth of uniQure? uniQure revenue growth between 2023 and 2024 was 71%.
Is uniQure profitable? Yes, uniQure is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.